<unk>  is used in the European Union to prevent phototoxicity in adults with erythropoietic protoporphyria (EPP). It is an implant that is injected and placed under the skin; an implant lasts two months. People who have severe liver disease, liver impairment, or kidney impairment, should not use this drug. Pregnant women should not take it, and women who are active sexually should use contraception while they are taking it. It is not known if<unk>  is secreted in breast milk.
Afamelanotide
Efgartigimod alfa
Astemizole
Crofelemer
Promazine
Tecovirimat
Viaspan
Retinol